Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) currently has a daily average trading volume of 2.77M but it saw 1914721 shares traded on Thursday. With a market cap of 2.91M USD, stock’s current market price of $0.13 came falling about -0.23 while comparing to the previous closing price of $0.13. In past 52 weeks, the stock remained buoying in the range of price level as high as $20.80 and as low as $0.13. In the recent trading on the day, stock has struck highest price mark of $0.1355 while lowest mark touched by it was $0.125.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Taking a look at 20-day trading activity of Biodexa Pharmaceuticals Plc (BDRX) gives us an average price of $0.2103, while its current price level is -99.37% below from 52-week high level whereas it is 2.73% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4168 while that of 200 days or SMA-200 reads an average of $5.1925. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.27% during that period while stretching the period over a month that increases to 13.32%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 21.55 which implies that the stock is in oversold territory.
Data by FactSet Research shows that 1 analysts have issued their ratings for the stock. 0 of them are in opinions that stock is a Sell, while 0 are advising it as an Overweight. 0 analysts suggested the investors to Buy the stock while 1 advised them to Hold.
Over the week, BDRX’s stock price is moving -37.38% down while it is -49.40% when we observe its performance for the past one month. Year-to-date it is -96.66% down and over the past year, the stock is showing a downside performance of -98.83%.
In next quarter, company is expected to be making quarterly sales of $370k as analysts are expecting the sales for current fiscal year at $1.22 million and seeing the company making $1.22 million in sales next year. Moreover, analysts are in estimates of $240k for current-quarter revenue.
Currently, Biodexa Pharmaceuticals Plc’s total number of outstanding shares is 18.93M with 0.00% of that held by the insiders while 2.11% of its common stock has been owned by the institutions. Stock’s beta reads 2.11. Stock has a price to book (P/B) ratio of 0.05 while price to sale or P/S ratio amounts to 3.64.
A filing at the U.S. Securities and Exchange Commission revealed that Fidelity Nasdaq Composite Index F came shrinking its share ownership by -0.27% in the Biodexa Pharmaceuticals Plc (BDRX) decreasing its stake to 0.00% with control over 1.0 shares in the company.
